TTGT:NASDAQTechTarget, Inc. Analysis
Data as of 2026-05-06 - not real-time
$5.95
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
TechTarget, Inc. is trading at a steep discount to its intrinsic valuation, with the DCF model indicating a fair value far above the current market price. Revenue is growing at roughly 40% YoY and gross margins sit comfortably above 60%, but operating efficiency remains weak, reflected in a sub‑10% operating margin and a negative trailing profit margin. The forward earnings outlook turns positive, and a consensus of three analysts rates the stock as a strong buy, reinforcing the upside narrative. Despite the lack of dividend payments, the balance sheet shows modest cash relative to debt, and free cash flow is positive, suggesting the company can sustain operations while it works toward profitability.
On the technical side, the stock sits in the overbought region of the RSI, while the MACD line has recently crossed above its signal, signaling short‑term bullish momentum that may be fragile. Volume trends are decreasing and the 30‑day volatility exceeds 80%, indicating a potentially choppy price environment. The beta above 1.3 points to heightened sensitivity to market swings, and the price is positioned between a clear support level near $3.60 and resistance around $6.20, leaving limited upside in the immediate term but substantial room for a longer‑term rally if fundamentals materialize.
On the technical side, the stock sits in the overbought region of the RSI, while the MACD line has recently crossed above its signal, signaling short‑term bullish momentum that may be fragile. Volume trends are decreasing and the 30‑day volatility exceeds 80%, indicating a potentially choppy price environment. The beta above 1.3 points to heightened sensitivity to market swings, and the price is positioned between a clear support level near $3.60 and resistance around $6.20, leaving limited upside in the immediate term but substantial room for a longer‑term rally if fundamentals materialize.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in overbought territory suggests limited near‑term upside
- Decreasing volume and high short‑term volatility
- Price near resistance with limited catalyst in the next few weeks
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and improving cash flow
- DCF valuation indicating ~68% upside potential
- Analyst consensus of strong‑buy and favorable forward EPS
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Undervalued relative to industry PE and intrinsic fair value
- Strategic positioning in intent‑driven advertising and AI‑enhanced solutions
- Potential for margin expansion as operating efficiencies improve
Key Metrics & Analysis
Financial Health
Revenue Growth40.10%
Profit Margin-207.13%
P/E Ratio7.3
ROE-93.08%
ROA-1.26%
Debt/Equity18.71
P/B Ratio0.7
Op. Cash Flow$16.3M
Free Cash Flow$77.5M
Industry P/E37.2
Technical Analysis
TrendNeutral
RSI71.9
Support$3.61
Resistance$6.20
MA 20$5.05
MA 50$4.33
MA 200$5.35
MACDBullish
VolumeDecreasing
Fear & Greed Index90.48
Valuation
Fair Value$37.86
Target Price$10.00
Upside/Downside68.07%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.36
Volatility80.62%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.